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Figure S1 Immunofluorescent localization of NRP1 and CS and HS in HCASMCs and HUVECs
HCASMCs (A and B) and HUVECs (C) were fixed, permeabilized and then immunostained for NRP1 and co-stained with antibody for either CS (A and C) or HS (B). NRP1 is located in the cytoplasm
and also at the membrane of the cells (A and B) where it co-localizes (indicated by white arrowheads) with CS (A) and HS (B). In HUVECs (C), such co-localization was not observed and rather
distinct signals are seen for CS and NRP1. Parallel cultures of HCASMCs (A and B) were also treated with chondroitinase (Case) and heparitinase (Hase) before fixation and immunofluorescent
staining. Results are representative of at least three independent experiments.
SUPPLEMENTARY METHODS
Receptor binding assay in intact cells
Confluent HCASMCs, PAE cells and PAE/NRP1 cells cultured
in 24-well plates were washed twice with PBS. Binding medium
(Dulbecco’s modified Eagle’s medium and 25 mM Hepes, pH 7.3,
containing 0.1% BSA) was added, followed by addition of
0.1 nM 125I-PDGF-BB (1825 Ci/mmol; Perkin-Elmer) or 125I-
VEGF-A165 (1200–1800 Ci/mmol; GE Healthcare). After 2 h of
incubation at 4 ◦C, the medium was aspirated and cells were
washed four times with ice-cold PBS. The cells were then lysed
with 0.25 M NaOH and 0.5% SDS solution, and radioactivity in
the lysates was measured in a γ -counter. Non-specific binding
was determined in the presence of a 100-fold excess of unlabelled
PDGF-BB or VEGF-A165 (R&D Systems).
PDGFR assay
In these assays of PDGFRs, an immobilized capture antibody
specific for human PDGFR binds both tyrosine-phosphorylated
and unphosphorylated PDGFR. After washing away unbound
material, a biotinylated detection antibody specific for total
PDGFR is used to detect both tyrosine-phosphorylated
and unphosphorylated receptor, utilizing streptavidin–HRP
(horseradish peroxidase), whereas an HRP-conjugated detection
antibody specific for phosphorylated tyrosine is used to detect
only tyrosine-phosphorylated receptor, utilizing HRP. The capture
antibody was diluted to a working concentration of 4 μg/ml
in PBS, without carrier protein and 100 μl was immediately
added to a 96-well microplate for overnight incubation at room
temperature. The next day, each well was washed four times
with washing buffer (0.05% Tween 20 in PBS, pH 7.2) and
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Figure S2 VEGF does not induce migration or signalling in HCASMCs
(A and B) HCASMCs transferred to transwells were stimulated to migrate for 4 h in response to serum-free medium (Control), 30 ng/ml PDGF-BB or 30 ng/ml VEGF-A165 (A), or in response to the
indicated VEGF concentrations (B). Cells were stained and counted as described in the Materials and methods section of the main text. Results are mean+S.E.M. (n = 3) numbers of migrated cells
obtained from multiple independent experiments. *P < 0.05 compared with control. (C) Confluent HCASMCs or HUVECs were treated for 10 min with the indicated concentrations (all ng/ml) of
VEGF-A165, PDGF-AA or PDGF-BB. Lysates were prepared and blotted with the antibodies indicated. Results are representative of three independent experiments. Molecular masses are indicated
in kDa.
blocked for 2 h with 300 μl of PBS containing 1% BSA.
Wells were washed again three times before adding 100 μl
of lysate prepared in the following diluent: 1% Nonidet P40,
20 mM Tris/HCl (pH 8.0), 137 mM NaCl, 10% glycerol, 2 mM
EDTA and 1 mM activated sodium orthovanadate. The same
diluent without protein was used as a blank. The plate was
left to incubate for 2 h at room temperature and washed again.
Then, 100 μl of detection antibody diluted to the manufacturer’s
recommendations in 20 mM Tris/HCl, 137 mM NaCl, 0.05%
Tween 20 and 0.1% BSA (pH 7.2) was added directly to the
well, before incubation for a further 2 h. When measuring total
PDGFR levels, the following extra step was required: after
another three washes, streptavidin–HRP was diluted according
to the manufacturer’s recommendations in the same buffer as
the detection antibody and 100 μl was added to each well
for 20 min at room temperature. Finally, 100 μl of substrate
solution was added to each well for 20 min, followed by
50 μl of stop solution. The absorbance of each well was
determined immediately, using a microplate reader set to 450 nm
with wavelength correction of 595 nm. The values obtained for
phospho-PDGFRs were normalized using the values obtained for
total PDGFRs.
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Figure S3 PDGFRβ and NRP1 do not co-localize in HCASMCs
HCASMCs were fixed, permeabilized and then immunostained for NRP1 (green) and co-stained
with antibody for PDGFRβ (red). NRP1 is located in the cytoplasm and also at the membrane of
the cells, and in the merge shows little co-localization with PDGFRβ in the membrane (bottom
panels). Some co-localization can be observed in the cytoplasm (white arrowheads).
Table S1 Binding of 125I-PDGF-BB or 125I-VEGF-A165 was determined in
intact confluent cultures of HCASMCs, PAE cells or PAE/NRP1 cells in the
presence or absence of a 100-fold excess of unlabelled PDGF-BB or VEGF
Non-specific binding was defined as that which is not competed by an excess of unlabelled
ligand. Specific binding was calculated by subtracting non-specific binding from total counts.
Results are mean counts (c.p.m.) obtained from three independent experiments, with each
experiment being performed in triplicate wells. Percentages of total binding are indicated in
parentheses.
125I-ligand binding (c.p.m.)
Growth factor Cell type Total Non-specific Specific
PDGF-BB HCASMCs 6542 (100) 2600 (40) 3942 (60)
PAE cells 13899 (100) 11857 (85) 2042 (15)
PAE/NRP1 cells 13363 (100) 10626 (80) 2737 (20)
VEGF HCASMCs 1595 (100) 726 (46) 868 (54)
PAE/NRP1 cells 4137 (100) 688 (17) 3448 (83)
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Figure S4 PDGF-stimulated p130Cas phosphorylation is mediated via NRP1
HCASMCs were transfected with control scrambled siRNA (scr) or with NRP1 siRNA, and
3 days later, cells were incubated overnight in serum-free medium and then treated for the
times indicated (in min) with 30 ng/ml PDGF-BB. Cells were then lysed and immunoblotted
with the antibodies indicated. The results shown are representative of at least three independent
experiments. Molecular masses are indicated in kDa.
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